MAY 12, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Ziextenzo (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling change to pegfilgrastim-bmez (Ziextenzo); regulatory action without clinical trial data.
Reported
Approval date2026-05-12
Dosage strength6 mg/0.6 mL